Im probably drawing a long bow here but the CSIRO paper says.:
"The repair of cardiac tissue with cells delivered by an appropriate bioscaffold is expected to offer a superior, long-lasting treatment strategy."
The other cardiocell ..with 2 Ls in the spelling is focussed on the injection of stem cells into the damaged heart muscle of people who have heart attacks.
I wonder if some cardiocel material placed inside the damaged muscle may assist the cardiocell injection method?
So many opprtunities for AHZ to consider.
fox
- Forums
- ASX - By Stock
- GreatExposure
Im probably drawing a long bow here but the CSIRO paper says.:...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.97 |
Change
-0.530(4.61%) |
Mkt cap ! $233.8M |
Open | High | Low | Value | Volume |
$11.50 | $11.50 | $10.91 | $108.6K | 9.829K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 79 | $10.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.00 | 67 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23 | 11.040 |
2 | 503 | 11.000 |
1 | 180 | 10.990 |
4 | 328 | 10.980 |
1 | 100 | 10.950 |
Price($) | Vol. | No. |
---|---|---|
11.120 | 338 | 3 |
11.130 | 126 | 1 |
11.160 | 117 | 1 |
11.170 | 180 | 1 |
11.180 | 180 | 1 |
Last trade - 14.52pm 17/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online